Table 2.
# | Sex | Age (years) | TNM | Mutation status | Mucine status | Analyzed tissues | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
EGFR | KRAS | BRAF | ERBB2 | PIK3CA | ALK | Tumoral | Normal | |||||
Lepidic | ||||||||||||
923 | Female | 50 | T1bN0M0 | ND | ND | ND | ND | ND | ND | Nonmucinous | Yes | No |
974 | Male | 58 | T4N0M0 | ND | ND | ND | ND | ND | ND | Unspecified | Yes | No |
975 | Female | 79 | a | ND | ND | ND | ND | ND | ND | Mucinous | Yes | No |
979 | Female | 76 | ND | ND | ND | ND | ND | ND | ND | Unspecified | Yes | No |
1030 | Female | 53 | T1bN0M0 | ND | ND | ND | ND | ND | ND | Unspecified | Yes | No |
1042 | Male | 40 | T1bN0M0 | ND | ND | ND | ND | ND | ND | Unspecified | Yes | No |
2363 | Male | 53 | T2bN0M0 | ND | ND | ND | ND | ND | ND | Unspecified | Yes | No |
2532 | Female | 66 | T1aN0M0 | – | + | – | – | – | – | Nonmucinous | Yes | Yes |
2533 | Male | 78 | T3N0M0 | – | – | + | – | – | – | Mucinous | Yes | Yes |
2534 | Male | 46 | T1bN0M0 | – | + | – | – | – | – | Nonmucinous | Yes | Yes |
2535 | Female | 76 | T1aN0M0 | – | – | – | – | – | – | Nonmucinous | Yes | Yes |
2537 | Male | 62 | T2aN0M0 | – | ND | + | – | – | – | Nonmucinous | Yes | Yes |
2538 | Male | 54 | T2bN0M0 | – | + | – | – | – | – | Mixed | Yes | Yes |
Papillary | ||||||||||||
2536 | Female | 54 | T3N2M0 | – | ND | + | – | – | – | Mucinous | Yes | Yes |
2539 | Male | 61 | T3N0M0 | – | ND | ND | ND | ND | ND | ND | Yes | Yes |
2540 | Male | 61 | T3N1M0 | – | ND | ND | ND | ND | ND | ND | No | Yes |
2541 | Male | 63 | T1N0M0 | – | – | – | – | – | – | ND | Yes | Yes |
2542 | Female | 51 | T1N0M0 | – | – | + | – | – | – | ND | Yes | Yes |
2543 | Female | 83 | T2bN2M0 | – | – | + | – | – | ND | ND | Yes | No |
ND: not determined (or not known), TNM: tumor node metastasis staging.
aLesions from patient 975 were described as predominantly lepidic with a contingent of acinar lesions; the TNM was not determined.